Smoking Cessation: Unveiling Challenges for Substance Users
Episode Overview
Low usage of cessation aids among adults with substance use issues. Demographic disparities in cessation aid utilisation. Need for innovative public health interventions. Surprising findings on e-cigarette effectiveness over time. Call for increased accessibility to cessation products.
"It's just absolutely unacceptable that only 10% of people with high substance use problems used NRT at least once in the past year."
Ever wondered how smoking cessation efforts pan out for adults dealing with substance use issues? Dr Zoe Swithenbank takes the mic to chat with Dr Olufemi Erinoso and Dr Jennifer Pearson about their enlightening research. The duo dives into their study using data from the Population Assessment of Tobacco and Health (PATH) Study, spanning from 2013 to 2021. They discuss the surprising findings on the use of cessation products among those with substance use problems.
One standout revelation is the shockingly low use of FDA-approved cessation aids like nicotine replacement therapies and medications such as varenicline among this group. Femi and Jenny uncover that, contrary to expectations, these aids are underutilised not just by those with substance use disorders but across the board. The conversation also touches on demographic disparities, highlighting lower cessation aid usage among Hispanic and Non-Hispanic Black populations compared to their white counterparts.
The episode is a call to action for innovative solutions to increase accessibility and engagement with cessation products, aiming to bridge these gaps. With a blend of data-driven insights and personal anecdotes, this episode offers a fresh perspective on smoking cessation challenges and the dire need for public health intervention. Whether you're a researcher, clinician, or someone with lived experience, there's plenty to reflect on here. So, what innovative strategies can we implement to make cessation aids more accessible?
Join the discussion and ponder the possibilities.